Skip to content

call today for a free consultation

New York Personal Injury Attorneys

New York Personal Injury Attorney Blog

Controversial Herbicide, Paraquat, Linked to Parkinson’s Disease

Over the last decade, studies conducted on the controversial, yet commonly used herbicide Paraquat, demonstrate its links to an increased risk of Parkinson’s disease. Although manufacturers have been aware of the link between Paraquat and serious health risks, the herbicide continues to be sold without adequate warnings. What is Paraquat and Why is it Controversial?…

Read More

FDA Issues a Class One Recall on Medtronic Catheters

On November 3, 2020, the Food and Drug Administration  (FDA) issued a Class I recall, the most serious type of recall, for the Medtronic Rashkind Balloon Septostomy Catheter. The recall follows at least one reported death and two severe injuries sustained by Medtronic catheter users. The catheters are used during surgery to create an atrial…

Read More

New York Product Liability: Belviq Cancer Lawsuits Rise After FDA Orders Product Withdrawal

On February 13th, 2020, the Food and Drug Administration asked pharmaceutical distributor Eisai Inc. to voluntarily pull their weight loss drug Belviq off the market after a five-year study conducted on Belviq pointed to a link between the drug and cancer.    What is Belviq, the Popular Weight Loss Drug Recalled by the FDA?  …

Read More

Johnson & Johnson Talcum Powder Litigation Continues to Grow

A series of key decisions in multiple courts across the country have gone against Johnson & Johnson in the talcum powder litigation. Most recently, on August 5th, 2020, a New Jersey state appeals court reinstated lawsuits dismissed four years ago that claim Johnson & Johnson’s talcum powder products caused ovarian cancer. The lawsuits were revived…

Read More

FDA Requests Removal of Ranitidine (Zantac) Products From Market for Potential Carcinogen

On April 1st, the Food and Drug Administration (FDA) announced its request for all prescription and over-the-counter ranitidine drugs to be removed from the market immediately. This decision was made based on an ongoing investigation of the potential risk of N-nitrosodimethylamine, or NDMA, to public health. Here, the product liability attorneys at Sullivan Papain Block…

Read More

Free Case Evaluation

Our fee is on a contingency basis. If we don’t recover money for you, we will never charge you. If you are unable to come to any of our offices, we are happy to visit you at home or in the hospital.

*Field Required